Show simple item record

Guidelines for the control of glycopeptide-resistant enterococci in hospitals.

dc.contributor.authorCookson, B D
dc.contributor.authorMacrae, M B
dc.contributor.authorBarrett, S P
dc.contributor.authorBrown, D F J
dc.contributor.authorChadwick, Claire
dc.contributor.authorFrench, G L
dc.contributor.authorHateley, P
dc.contributor.authorHosein, I K
dc.contributor.authorWade, J J
dc.date.accessioned2009-07-07T16:38:13Z
dc.date.available2009-07-07T16:38:13Z
dc.date.issued2006-01
dc.identifier.citationGuidelines for the control of glycopeptide-resistant enterococci in hospitals. 2006, 62 (1):6-21 J. Hosp. Infect.en
dc.identifier.issn0195-6701
dc.identifier.pmid16310890
dc.identifier.doi10.1016/j.jhin.2005.02.016
dc.identifier.urihttp://hdl.handle.net/10541/72845
dc.description.abstractThe increase since the mid 1980s in glycopeptide resistant enterococci (GRE) raised concerns about the limited options for antimicrobial therapy, the implications for ever-increasing numbers of immunocompromised hospitalised patients, and fuelled fears, now realised, for the transfer of glycopeptide resistance to more pathogenic bacteria, such as Staphylococcus aureus. These issues underlined the need for guidelines for the emergence and control of GRE in the hospital setting. This Hospital Infection Society (HIS) and Infection Control Nurses Association (ICNA) working party report reviews the literature relating to GRE prevention and control. It provides guidance on microbiological investigation, treatment and management, including antimicrobial prescribing and infection control measures. Evidence identified to support recommendations has been categorized. A risk assessment approach is recommended and areas for research and development identified.
dc.language.isoenen
dc.subject.meshAnti-Bacterial Agents
dc.subject.meshCross Infection
dc.subject.meshDrug Resistance, Bacterial
dc.subject.meshEnterococcus
dc.subject.meshGlycopeptides
dc.subject.meshGram-Positive Bacterial Infections
dc.subject.meshHospitals
dc.subject.meshHumans
dc.subject.meshInfection Control
dc.subject.meshVancomycin Resistance
dc.titleGuidelines for the control of glycopeptide-resistant enterococci in hospitals.en
dc.typeArticleen
dc.contributor.departmentLaboratory of Healthcare Associated Infection, Specialist and Reference Microbiology Division, Health Protection Agency, London, UK.en
dc.identifier.journalThe Journal of Hospital Infectionen
html.description.abstractThe increase since the mid 1980s in glycopeptide resistant enterococci (GRE) raised concerns about the limited options for antimicrobial therapy, the implications for ever-increasing numbers of immunocompromised hospitalised patients, and fuelled fears, now realised, for the transfer of glycopeptide resistance to more pathogenic bacteria, such as Staphylococcus aureus. These issues underlined the need for guidelines for the emergence and control of GRE in the hospital setting. This Hospital Infection Society (HIS) and Infection Control Nurses Association (ICNA) working party report reviews the literature relating to GRE prevention and control. It provides guidance on microbiological investigation, treatment and management, including antimicrobial prescribing and infection control measures. Evidence identified to support recommendations has been categorized. A risk assessment approach is recommended and areas for research and development identified.


Files in this item

This item appears in the following Collection(s)

Show simple item record